SHANDONG SCIENCE ›› 2015, Vol. 28 ›› Issue (3): 29-33.doi: 10.3976/j.issn.1002-4026.2015.03.006

• Pharmacology and Toxicology • Previous Articles     Next Articles

Protection effect of resveratrol to astemizoleinduced cardiac injury of zebrafish embryos

XUE Di1,2, HAN Liwen2, YANG Jifang3, HE Qiuxia2,WANG Xue2,HOU Hairong2,ZHANG Aiping1*, LIU Kechun2*   

  1. 1. School of Pharmacy, Shanxi Medical University, Taiyuan 030001,China; 2. Shandong Provincial Key Laboratory of Biosensors,Biology Institute, Shandong Academy of Sciences, Jinan 250014, China; 3. Department of Nursing, The First People's Hospital of Qingdao Development Zone, Qingdao 266555, China
  • Received:2015-04-02 Published:2015-06-20 Online:2015-06-20

Abstract: We explore the protection effect of different concentrations resveratrol to astemizoleinduced cardiac injury of zebrafish embryos.We treat zebrafish embryos with 4 μmol/L astemizole and different concentrations resveratrol with normal growth 48 hpf zebrafish embryo as an experimental model.We observe cardiac phenotypes, heart rates and the variation of SVBA at 72 hpf. Astemizole group shows heart injury such as pericardium edema, blood cell accumulation around the heart, heart rate reduction and SVBA interval shortening after drug feeding. However, astemizoleinduced heart toxicity significantly decreases with the increase of resveratrol concentration for resveratrol group.We therefore think resveratrol can protect astemizoleinduced cardiac injury of zebrafish embryos.

Key words: cardiac injury, heart rate, astemizole, resveratrol, protection, zebrafish

CLC Number: 

  • R965.1

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0), which permits third parties to freely share (i.e., copy and redistribute the material in any medium or format) and adapt (i.e., remix, transform, or build upon the material) the articles published in this journal, provided that appropriate credit is given, a link to the license is provided, and any changes made are indicated. The material may not be used for commercial purposes. For details of the CC BY-NC 4.0 license, please visit: https://creativecommons.org/licenses/by-nc/4.0